Featured Story

Still got it: Tips and tricks to keep your older pharma plant riding high

In pharma plants, age definitely matters

PM1905 WebLeadImage 295X269

Everything you do in life catches up to you eventually. And just like the state of your complexion, pharmaceutical equipment loses its pep over time and cracks around the edges. Of course, these breakdowns are not only cosmetic. Without proper maintenance and occasional upgrades, old and faulty pharma equipment can increase the risk of contamination, which can trigger recalls and quality-related disruptions in production that don’t just slow down work at one plant — they can also be a major contributor to U.S. drug shortages.In pharma plants, age definitely matters.Ironically, there’s no shortage of new equipment that manufacturers can buy to replace their older…

Full Story

Pharma Manufacturing Exclusives


On-demand, concise audio and powerpoint tutorials on the fundamental concepts of pharmaceutical manufacturing, process development, quality control and compliance.

Research Zone

A collection of news stories highlighting advances in medical science and pharmaceutical R&D.

Funny Pharm

Write a caption and win!

Aug15homepageBe sure to check out our newest cartoon created by award-winning artist Jerry King. He provides the artwork; you provide the funny caption!

Most Recent

  • Solid Dose: Under-hyped but not under-represented

    By Karen Langhauser, Chief Content Director

    Tablets may not be as glamorous or cutting-edge as emerging sectors of the biologics markets, but they have their upsides. Oral solid dose formulations are efficient and cost-effective to manufacture, shelf stable and easy to administer. Perhaps most importantly, they are understood and accepted by…

    Full Story
  • The future is transparent

    By Pierre-François Thaler Co-Founder and Co-CEO, EcoVadis

    It’s no doubt an interesting time for pharma. Competition is fierce in the tight race for new drug discovery. Many leading companies are merging and acquiring where they can to fill gaps in product portfolios and R&D and more importantly, gain access to new markets — especially the U.S.,…

    Full Story
  • INTERPHEX 2019: Still hip at forty

    By Karen Langhauser, Chief Content Director

    This year, INTERPHEX celebrated 40 years of showcasing state-of-the-art innovation and technology to positively impact pharma, bio and device development and manufacturing. Pharma Manufacturing editors spent three days walking the tradeshow floors at NYC’s Javits Center, looking at new products,…

    Full Story
  • How to boost your chances of winning an FDA drug approval

    By Dr. Harneet Arora, freelance clinical scientist, FDA regulations expert, Kolabtree

    According to a recent study from the Massachusetts Institute of Technology, only about 14 percent of all drugs in clinical trials gain approval from the FDA. This means that for 86 percent of all proposed new drugs, something goes wrong along the process towards commercialization, wasting time,…

    Full Story
  • Instrumental in profitability

    By Ravi Shankar Life Sciences Industry Manager, Endress+Hauser

    Blockbuster products have historically driven the market, and the profits of pharma companies. But since the late 1990s, many of the patents for these top-selling pharmaceuticals have expired. This has created challenges as pharma must now manufacture existing products much more efficiently to…

    Full Story
  • Revalidating grandpa

    By Karen Langhauser, Chief Content Director

    I am bored with reading articles about adjusting work environments to accommodate the growing list of “Millennial” demands. While I’ll never refute the value of keeping up with technology, the jury is still out on how an in-office barista, napping pods or a “bring your pet to work”…

    Full Story

Latest Products